论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
Authors Liu R, Wang F, Guo Y, Yang J, Chen S, Gao X, Wang X
Received 26 December 2017
Accepted for publication 4 May 2018
Published 16 July 2018 Volume 2018:11 Pages 4065—4073
DOI https://doi.org/10.2147/OTT.S160871
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Andrew Yee
Peer reviewer comments 3
Editor who approved publication: Dr Jianmin Xu
Purpose: We aimed to investigate the roles of microRNA-425 (miR-425) in
lung adenocarcinoma, as well as its possible regulatory mechanism.
Materials and methods: The miR-425 expression in lung adenocarcinoma tissues
and cells was determined. The regulatory relationship between miR-425 and
IL-6/STAT3 signaling was investigated. In addition, miR-425 was downexpressed
in H1299 cells, and its effects on cell proliferation and apoptosis were
determined. Furthermore, the target relationship between miR-425 and A
disintegrin and metalloproteinases 9 (ADAM9) in lung adenocarcinoma cells was
explored.
Results: The miR-425 was significantly downregulated in lung
adenocarcinoma tissues and cells and was markedly inhibited by IL-6/STAT3
signaling. In addition, miR-425 expression was successfully overexpressed by
transfection with pre-miR-425. Overexpression of miR-425 decreased the
proliferation and colony formation of H1299 cells and promoted cell apoptosis
markedly. Moreover, ADAM9 was revealed as a target of miR-425, and ADAM9
expression was negatively regulated by miR-425.
Conclusion: Our findings indicate that downregulation of miR-425
caused by IL-6/STAT3 signaling leads to loss of ADAM9 targeting, results in
enhanced ADAM9 expression, and contributes to the development of lung adenocarcinoma.
Thus, increasing miR-425 may be a promising therapeutic strategy for this
disease.
Keywords: lung
adenocarcinoma, microRNA-425, IL-6/STAT3 signaling, proliferation, apoptosis, A
disintegrin and metalloproteinases 9